Literature DB >> 21245484

Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling.

Kenrick Semple1, Antony Nguyen, Yu Yu, Honglin Wang, Claudio Anasetti, Xue-Zhong Yu.   

Abstract

CD28 costimulation is required for the generation of naturally derived regulatory T cells (nTregs) in the thymus through lymphocyte-specific protein tyrosine kinase (Lck) signaling. However, it is not clear how CD28 costimulation regulates the generation of induced Tregs (iTregs) from naive CD4 T-cell precursors in the periphery. To address this question, we induced iTregs (CD25(+)Foxp3(+)) from naive CD4 T cells (CD25(-)Foxp3(-)) by T-cell receptor stimulation with additional transforming growth factorβ (TGFβ) in vitro, and found that the generation of iTregs was inversely related to the level of CD28 costimulation independently of IL-2. Using a series of transgenic mice on a CD28-deficient background that bears wild-type or mutated CD28 in its cytosolic tail that is incapable of binding to Lck, phosphoinositide 3-kinase (PI3K), or IL-2-inducible T-cell kinase (Itk), we found that CD28-mediated Lck signaling plays an essential role in the suppression of iTreg generation under strong CD28 costimulation. Furthermore, we demonstrate that T cells with the CD28 receptor incapable of activating Lck were prone to iTreg induction in vivo, which contributed to their reduced ability to cause graft-versus-host disease. These findings reveal a novel mechanistic insight into how CD28 costimulation negatively regulates the generation of iTregs, and provide a rationale for promoting T-cell immunity or tolerance by regulating Tregs through targeting CD28 signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245484      PMCID: PMC3062312          DOI: 10.1182/blood-2010-08-301275

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Inducing and expanding regulatory T cell populations by foreign antigen.

Authors:  Karsten Kretschmer; Irina Apostolou; Daniel Hawiger; Khashayarsha Khazaie; Michel C Nussenzweig; Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-10-23       Impact factor: 25.606

2.  CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

Authors:  Xuguang Tai; Michelle Cowan; Lionel Feigenbaum; Alfred Singer
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

Review 3.  The role of the transcription factor Foxp3 in the development of regulatory T cells.

Authors:  Jeong M Kim; Alexander Rudensky
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

4.  Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells.

Authors:  Todd S Davidson; Richard J DiPaolo; John Andersson; Ethan M Shevach
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

5.  IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells.

Authors:  Song Guo Zheng; Juhua Wang; Pu Wang; J Dixon Gray; David A Horwitz
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

6.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Luke M Williams; James L Dooley; Andrew G Farr; Alexander Y Rudensky
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

7.  A function for interleukin 2 in Foxp3-expressing regulatory T cells.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-10-16       Impact factor: 25.606

8.  Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.

Authors:  Yaming Liang; Chen Liu; Julie Y Djeu; Bin Zhong; Thorsten Peters; Karin Scharffetter-Kochanek; Claudio Anasetti; Xue-Zhong Yu
Journal:  Blood       Date:  2007-10-10       Impact factor: 22.113

9.  A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant.

Authors:  Lindzy D Friend; Dulari D Shah; Christine Deppong; Joseph Lin; Traci L Bricker; Twyla I Juehne; Christine M Rose; Jonathan M Green
Journal:  J Exp Med       Date:  2006-08-14       Impact factor: 14.307

10.  All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation.

Authors:  Micah J Benson; Karina Pino-Lagos; Mario Rosemblatt; Randolph J Noelle
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

View more
  40 in total

1.  Protein kinase C-θ inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway.

Authors:  Jian Ma; Yan Ding; Xianfeng Fang; Ruiqing Wang; Zuoming Sun
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

2.  Efficient expansion of cryopreserved CD4(+)CD25(+)CD127(lo/-) cells in Type 1 diabetes.

Authors:  Anna Rydén; Maria Faresjö
Journal:  Results Immunol       Date:  2011-08-22

3.  Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.

Authors:  Simon Ville; Nicolas Poirier; Julien Branchereau; Vianney Charpy; Sabrina Pengam; Véronique Nerriere-Daguin; Stéphanie Le Bas-Bernardet; Flora Coulon; Caroline Mary; Alexis Chenouard; Jeremy Hervouet; David Minault; Steven Nedellec; Karine Renaudin; Bernard Vanhove; Gilles Blancho
Journal:  J Am Soc Nephrol       Date:  2016-05-09       Impact factor: 10.121

4.  Unregulated antigen-presenting cell activation by T cells breaks self tolerance.

Authors:  Jaeu Yi; Jisun Jung; Sung-Wook Hong; Jun Young Lee; Daehee Han; Kwang Soon Kim; Jonathan Sprent; Charles D Surh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-31       Impact factor: 11.205

Review 5.  Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function.

Authors:  Terrence L Geiger; Sharyn Tauro
Journal:  Hum Immunol       Date:  2011-12-27       Impact factor: 2.850

Review 6.  Rebalancing Immune Homeostasis to Treat Autoimmune Diseases.

Authors:  David A Horwitz; Tarek M Fahmy; Ciriaco A Piccirillo; Antonio La Cava
Journal:  Trends Immunol       Date:  2019-10-07       Impact factor: 16.687

7.  SRC1 promotes Th17 differentiation by overriding Foxp3 suppression to stimulate RORγt activity in a PKC-θ-dependent manner.

Authors:  Subha Sen; Fei Wang; Jing Zhang; Zhiheng He; Jian Ma; Yousang Gwack; Jianming Xu; Zuoming Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-27       Impact factor: 11.205

8.  The protein tyrosine phosphatase PTPN22 controls forkhead box protein 3 T regulatory cell induction but is dispensable for T helper type 1 cell polarization.

Authors:  G Fousteri; T Jofra; I Debernardis; S M Stanford; A Laurenzi; N Bottini; M Battaglia
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

Review 9.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  Regulatory T-cell immunotherapy for allogeneic hematopoietic stem-cell transplantation.

Authors:  Matthew Horch; Vu H Nguyen
Journal:  Ther Adv Hematol       Date:  2012-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.